Enhancing striatal acetylcholine facilitates dopamine release and striatal output in parkinsonian mice
Abstract Background L-DOPA has been considered the first-line therapy for treating Parkinson’s disease (PD) via restoring striatal dopamine (DA) to normalize the activity of local spiny projection neurons (SPNs) in the direct (dSPNs) pathway and the indirect (iSPNs) pathway. While the changes in str...
Saved in:
| Main Authors: | Hongxia Li, Ziluo Chen, Yuyan Tan, Huoqing Luo, Chen Lu, Chao Gao, Xin Shen, Fang Cai, Ji Hu, Shengdi Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Cell & Bioscience |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13578-024-01328-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Striatal Cholinergic Interneurons Control Physical Nicotine Withdrawal via Muscarinic Receptor Signaling
by: Baeksun Kim, et al.
Published: (2024-12-01) -
Complementary cognitive roles for D2-MSNs and D1-MSNs during interval timing
by: Robert A Bruce, et al.
Published: (2025-01-01) -
Associations between inflammation and striatal dopamine D2-receptor availability in aging
by: Vanessa Crine, et al.
Published: (2025-01-01) -
Knocking Out TAAR5: A Pathway to Enhanced Neurogenesis and Dopamine Signaling in the Striatum
by: Anastasia N. Vaganova, et al.
Published: (2024-11-01) -
Action inflexibility and compulsive-like behavior accompany neurobiological alterations in the anterior orbitofrontal cortex and associated striatal nuclei
by: Laura M. Butkovich, et al.
Published: (2025-01-01)